Cargando…
Real-world outcomes and toxicity of adjuvant chemotherapy in NSCLC: a single-center experience
AIM: Adjuvant chemotherapy in NSCLC is associated with modest benefits and significant toxicity. We sought to evaluate the toxicity of adjuvant chemotherapy and disease-specific outcomes in a real-world population. METHODS: We performed a retrospective analysis of patients undergoing adjuvant chemot...
Autores principales: | Cronin, Christopher, Iqbal, Shahid, Farooq, Abdul R, O'Dea, Pauline, Burke, Louise, O'Reilly, Seamus, O'Mahony, Deirdre, Power, Derek G, Bambury, Richard M, Collins, Dearbhaile C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241113/ https://www.ncbi.nlm.nih.gov/pubmed/37283858 http://dx.doi.org/10.2217/lmt-2022-0014 |
Ejemplares similares
-
A pilot project investigating the use of ONCOpatient®—An electronic patient-reported outcomes app for oncology patients
por: Macanovic, Bojan, et al.
Publicado: (2023) -
Current Irish medicolegal landscape: an unsustainable trajectory
por: Forrest, Clara, et al.
Publicado: (2023) -
The impact of the COVID-19 pandemic on non-national doctors in Ireland
por: Carroll, Hailey K., et al.
Publicado: (2022) -
1751P Lessons from a pandemic: An audit of acute medical oncology admissions during SARS-CoV-2 outbreak
por: Ni Choinin, A., et al.
Publicado: (2020) -
Is flat dosing cost-effective? Re: ‘The same old story’: thoughts on
authorised doses of anticancer drugs
por: Farooq, Abdul R., et al.
Publicado: (2020)